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1. Introduction 
Human diet comprises of milk and milk products in both developed and developing parts 
of globe. Milk fat is the major energy source in Indian diet but due to the fear of 
hypercholesterolemia, saturated fats have lead to avoidance of dietary fats especially of 
animal origin. However, milk contains a number of components with beneficial properties, 
one such compound associated with the fat phase is Conjugated Linoleic Acid (CLA) which 
has potential health benefits towards human beings. 
Conjugated Linoleic Acid (CLA) refers to a mixture of positional and geometric isomers of 
linoleic acid (cis-9, cis-12, C18:2) with two conjugated double bonds at various carbon 
positions in the fatty acid chain. It is formed as an intermediate during the 
biohydrogenation of linoleic acid by linoleic acid isomerase from the rumen bacteria 
Butyrivibrio fibrisolvens (Kritchevsky, 2000) or from the endogenous conversion of trans-11, 
C18:1 (Transvaccenic Acid) another intermediate of linoleic or linolenic acid 
biohydrogenation by ∆9-desaturase in the mammary gland (Corl et al., 2001).  
Milk fat is the richest natural dietary source of CLA. Milk contains an average 4.5mg 
CLA/g of fat (Kelly et al., 1998). Recent studies have shown that the CLA content of milk 
fat can be markedly enhanced by dietary manipulation especially those involving dietary 
addition of plant oils which are high in unsaturated fatty acids (Griinari and Bauman, 
1999). Dietary increase of linoleic acid (C18:2) and linolenic acid (C18:3) is one of the feeding 
strategies for increasing the CLA concentration in milk which is the main precursor of 
CLA. The main sources of linoleic acid for feeding animals are cereals, oil seeds, oils etc 
(Kelly et al., 1998) 
There is an increasing research interest towards the CLA and its potential health benefits 
such as anticarcinogenic, antiatherogenic, antidiabetic and immunomodulatory effects 
(Belury, 2002; Tyagi and kathirvelan, 2006). The potential anti-cancer effect of CLA is well 
documented, with the majority of experimental work conducted in vitro or in animal models 
(Ip et al., 1994).  It has been demonstrated that CLA has the ability to affect mammary 
cancer, stomach cancer, skin cancer and prostate cancer.  Most of the anticarcinogens are of 
plant origin but CLA is unique, it is present in food from animal sources and its anti-cancer 
efficacy is expressed at concentrations close to human consumption level. The unique 
structural and functional properties of CLA appear to modulate cellular process involved in 
carcinogenesis.  
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1.1 Chemical structure of CLA 
CLA is a term given to a group of positional and geometric isomers of linoleic acid (cis-9, cis-
12, C18:2 LA) in which double bonds are conjugated, instead of being in the typical 
methylene interrupted configuration. Each double bond can be cis or trans configuration 
giving rise to possible CLA isomers (Kelly et al., 1998). Although conjugation of double 
bonds occurs as part of free radical mediated oxidation of linoleic acid. CLA is a true isomer 
of LA, in that it does not possess additional oxygen (Vandenberg et al., 1995). 
 
 
 
 
 
 
1.2 Isomers of CLA 
CLA therefore, includes 28 positional and geometrical isomers of which only cis-9, trans-11 
and trans-10, cis-12 have thus far been proven to have biological activities (Park et al., 2003). 
Of the two physically important isomers cis -9, trans -11 (rumenic acid) is the most prevalent 
comprising 80-90% of the total CLA in food products from ruminants where as trans-10, cis-
12 is present in small amounts at 3-5% of total CLA (Parodi, 2003). Analysis of cheese using 
silver ion- high performance chromatography and G-C electron ionization mass 
spectrometry showed that isomers of CLA present (in fat percent) total CLA were cis-9, 
trans-11 (78-84%); trans-7, cis- 9 plus trans -8, cis -10 (8-13%); trans-11,cis-13 (1-2%); cis-
12,trans-14 (<1%) and the total trans/trans isomers (5-9%) (Parodi, 2003) 
1.3 Sources of CLA 
CLA occurs in many foods, however, the principal dietary sources are dairy products and 
other foods derived from ruminants. The CLA content of some common foods is shown in 
(Table 1). 
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CH3 (CH2)5 (CH2)7 COOHC
H
C C C
HHH
CH3 (CH2)4 (CH2)8 COOHC
H
C C C
H
HH
cis-9, trans-11 CLA
trans-10, cis-12 CLA
 
Foodstuff Total  CLA 
(mg/g of fat) 
Foodstuff Total CLA 
(mg/g of fat) 
Dairy products Meats  
Homogenized milk 4.5 Ground beef 4.3 
Condensed milk 7.0 Lamb 5.6 
Butter milk 6.1 Pork 0.6 
Mozzarella cheese 4.9 Chicken 0.9 
Plain yogurt 4.8 Salmon 0.3 
Ice-cream 3.6 Ground turkey 2.5 
Table 1. CLA content of common foods (Chin et al., 1992) 
2. Biosynthesis of CLA  
CLA found in milk and meat of ruminants originates from two sources (Griinari and 
Bauman, 1999). CLA is formed during ruminal biohydrogenation of linoleic acid and the 
second source is CLA synthesized by animal tissues from trans-11 C18:1, another intermediate 
in the biohydrogenation of unsaturated fatty acid. Hence, the uniqueness of CLA in 
ruminant edible products relates to incomplete biohydrogenation of dietary unsaturated 
fatty acids in the rumen. 
2.1 CLA synthesis in the rumen 
Dietary lipids undergo two important transformations in the rumen (Devillard et al., 2004). 
First, lipolysis - hydrolysis of ester linkages catalyzed by microbial lipase and second, 
biohydrogenation of unsaturated fatty acid. 
The first reaction in linoleic acid (cis-9, cis-12) biohydrogenation is isomerization of the cis-12 
double bond. Linoleate isomerase is the enzyme responsible for forming conjugated double 
bonds from the cis-9, cis-12 double bond structure of linoleic as well as α and γ linolenic 
acids. The enzyme is bound to the bacterial cell membrane and demonstrates an absolute 
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substrate requirement for a cis-9, cis-12 diene system and a free carboxyl group. The second 
reaction is a reduction in which cis-9, trans-11 CLA is converted to trans-11 C18:1(trans-
vaccenic acid). Isomerization of the cis-12 double bond was followed by rapid conversion of 
cis-9, trans-11 CLA to trans-11 octadecenoic acid. Hydrogenation of the trans-11 monoene 
occurred less rapidly, and it increased in concentration (Qiu, 2004). Therefore, trans-11 C18:1 
reduction seems to be rate-limiting in the biohydrogenation sequence of unsaturated C18 
fatty acids. As a consequence, this penultimate biohydrogenation intermediate accumulates 
in the rumen and is, therefore, more available for absorption. 
Similar to biohydrogenation of linoleic acid, biohydrogenation of linolenic acid begins with 
an isomerization followed by a sequence of reductions and terminates with the formation of 
stearic acid. Rumen biohydrogenation of α-linolenic acid produces cis-9, trans-11, cis-15 
conjugated octadecatrienoic acid as the predominant initial isomerization product, and this 
is followed by reduction of the cis-double bonds. As a consequence, trans-11 octadecenoic 
acid is a common intermediate in the biohydrogenation of both α-linolenic acid and linoleic 
acid (Fig.1) 
 
 
2.2 Endogenous synthesis  
Griinari and Bauman (1999) proposed that a major proportion of CLA in tissue and milk 
lipids synthesized endogenously from trans vaccenic acid (TVA) by 9 – desaturase, in 
mammary gland (Fig.1). Griinari et al (2000) examined the potential for endogenous 
synthesis of CLA by infusing TVA abomasally and measuring the changes in milk fat CLA. 
By day three it resulted in a 31% increase in milk fat CLA indicating that an active pathway 
for endogenous synthesis existed in the mammary gland. 
Griinari et al. (2000) reported that the contribution of endogenous synthesis to the over all 
CLA content in milk fat was 84%, making it the primary source. Lock and Garnsworthy 
(2002) estimated the endogenous synthesis of CLA to be more than 80% of total collected 
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duodenal samples and estimated the rumen synthesis of CLA to be 4-7%. Endogenous cis-9, 
trans-11 CLA would originate from desaturation of trans-11 C18:1 by delta-9 desaturase (Fig. 
1).  The enzymatic reaction introduces a cis double bond between carbons 9 and 10 of fatty 
acids. 
 
CLA Biosynthesis in Ruminants
C18:3∆C-9 C-12 C-15
(Linolenic acid)
C18:2∆ t-11 C-15
C18:1∆ t-11
(TVA)
C18:0
(Stearic acid)
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∆ 9 desaturase
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Fig. 1. CLA Biosynthesis in Ruminants 
3. Role of rumen bacteria in CLA synthesis 
Ruminants rely on microbial digestion of forages and supplementary feed materials in the 
rumen to provide nutrients that would otherwise be unavailable to the host animal. 
Ruminant diets typically contain polyunsaturated fatty acids, which are toxic to many 
rumen microorganisms (Harfoot and Hazlewood, 1997). However, to protect themselves 
against these toxic effects, rumen microorganisms have mechanisms to hydrolyse and 
biohydrogenate dietary lipids (Kemp and Lander, 1984).  
Rumen bacteria play a major role in biohydrogenation. They convert C18 unsaturated fatty 
acids to stearic acid, via a number of intermediates. Biohydrogenation intermediates have 
received a lot of attention recently because of their potential effects on human health. CLA 
and trans vaccenic acid are one of the intermediates of fatty acid biohydrogenation in the 
rumen. 
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3.1 Biohydrogenation of unsaturated fatty acid by rumen bacteria  
Rumen fluid contains bacteria, fungi and protozoa. Small amount of contribution is made by 
fungi and protozoa in biohydrogenation. Among which the major source of 
biohydrogenation is bacteria when compared to fungi and protozoa (Nam and 
Garnsworthy, 2007).  Bacteria involved in biohydrogenation process can be divided into two 
groups i.e., A and B  
Group A bacteria: They hydrogenate linoleic and linolenic acid to trans-11 octadecadienoic 
acid, and are not able to or incapable of hydrogenating octadecadienoic acid. Examples are 
Butyrovibrio, Micrococcus, Ruminococcus and Lactobacillus. 
Group B bacteria: They are capable of hydrogenating a wide range of octadecadienoic acids, 
including cis-9 (oleic) and trans-11 (transvaccenic) acids as well as linoleic acid to stearic 
acid. Examples are Fusocillus Sp and gram negative rods. 
More than 250 bacterial strains from 14 genera were examined and strains belonging to the 
genera Enterococcus, Micrococcus, Propionobacterium and Lactobacillus were found to produce 
considerable amounts of CLA from linoleic acid.  
Butyrivibrio fibrisolvens 
CLA formation in rumen has mainly been associated with bacterial activity. The ruminal 
bacterium Butyrivibrio fibrisolvens has been used as a model for cis-9, trans-11 CLA 
production (Grinarii et al., 2000). Butyrivibrio fibrisolvens a gram negative curved rod, strict 
anaerobic bacteria of moderate butyric acid producers with potent linoleic acid isomerase 
activity by using roll tube technique with ATCC media from rumen of cross bred cattle (Fig 
2; Fig 3),has been isolated in our lab and research work is under publication. 
 
 
Fig. 2. Translucent colony of Butyrivibrio Sp in roll tube. 
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Fig. 3. Gram – ve, curved/straight rods of Butyrivibrio Sp. 
3.2 Bacteria other than rumen origin involved in CLA synthesis 
In addition to rumen microflora, microbial CLA production has also been reported in 
Propionibacteria freudenreichii used as dairy starter cultures (Jiang et al., 1998). Ogawa et al., 
(2005) reported the production of CLA from free linoleic acid by Lactobacillus acidophilus. 
Kishino et al., (2002) found that Lactobacillus plantarum formed high levels of CLA from free 
linoleic acid upon extended incubation. Bifidobacteria also produce CLA, mainly the cis-9, 
trans-11 isomer (Coakley et al., 2003).  
4. Factors affecting CLA content in milk 
A cow’s diet, breed, age, non-nutritive feed additives, such as ionophores (Table 2) can 
affect the CLA content in milk fat. Among these factors, the diet is known to strongly 
influence the CLA content of milk and includes feedstuffs such as pasture, conserved 
forages, plant seed oils, cereal grains, marine oils and feeds and animal fat.  
4.1 Lipolysis and biohydrogenation in rumen 
Any change in the process of lipolysis or biohydrogenation will influence the supply of their 
intermediate and end products, including CLA, to the small intestine and ultimately their 
contents in the milk and meat. Replacement of forages with grain in the diet reduced the 
rates of lipolysis and biohydrogenation (Gerson et al., 1985). Increased proportion of 
nitrogen in the diet resulted in increased rates of lipolysis and biohydrogenation by rumen 
contents in vitro (Gerson et al., 1983). Lipolysis and hydrogenation reactions were more rapid 
with feed particles ranging from 1-2 mm size than from 0.1 to 0.4 mm size and this was due, 
at least in part, to microbial population density (Gerson et al., 1988). Biohydrogenation of 
fatty acids averaged 47% in the rumen of cows fed diets containing calcium salts of palm oil 
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and 71% with diets containing fat from animal or vegetable sources (Wu and Palmquist, 
1991). Factors affecting ruminal fermentation and microbial population are undoubtedly the 
keys to control the regulation of biohydrogenation and CLA synthesis. 
4.2 Diet, feed to the animal 
CLA are highly correlated with either linoleic or alpha linolenic acid intake. It is well known 
that linoleic and linolenic acid are both indirect precursors of the CLA isomer cis-9, trans-11 
(Aii et al., 1999) but the highest concentration of this CLA isomer is generally obtained with 
linolenic acid rich diets (Dhiman et al., 2000).  Dhiman et al., (1999) reported that cows 
grazing pasture had 500% higher CLA content in milk fat compared to cows fed a diet 
containing 50% conserved forage (hay and silages) and 50% grain. Tyagi et al (2007) reported 
that three fold (187 %) increase in total CLA content in milk of cow and buffaloes by feeding 
berseem fodder than the concenrtae feeding. About 48 to 56% of the total fatty acids in fresh 
forages consist of C18:3 (Bauchart et al., 1984) and form substrate for ruminal 
biohydrogenation.   
 
Dietary Factor Effect on CLA Content of Milk Fat 
Lipid Substrate 
Unsaturated vs saturated fat  Increased by addition of unsaturated fat 
Type of plant oil  Greatest with oils high in C18:2
Level of plant oil  Dose dependent increase 
Calcium salts of plant oils  Increased as with free oils 
High oil plant feeds 
High oil corn  Minimal effect 
Soybeans  Heat processing will increase 
Rapeseed vs soybean  Similar effect 
Modifiers of Biohydrogenation 
Forage: concentrate ratio  Increased with high ratio 
Fish oils  Greater increase than with plant oils 
Monensin - ionophore  Variable effect 
Dietary buffers  Little effect 
Combination 
Pasture vs conserved forages  Higher on pasture 
Source: Bauman et al., (2001) 
Table 2. Different substrate (dietary factors) that affect CLA content in milk fat  
4.3 Rumen pH  
Rumen pH has an important role in maintaining a viable rumen environment suitable for 
Butyrivibrio fibrisolvens involved in the biohydrogenation of linoleic and linolenic acid. 
Ruminal pH of 6.0 or above has a positive effect on TVA and CLA content in rumen cultures 
(Troegeler-Meynadir et al., 2003). Qiu et al. (2004) observed that reduced ruminal pH reduces 
total and cellulolytic bacterial number and thus reduce biohydrogenation which in turn 
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increase CLA. Martin and Jenkins (2002) from their continuous culture data suggest that 
culture pH seems to have most influence on the production of trans-C18:1 and CLA isomers 
by mixed rumen bacteria. When mixed ruminal bacteria were maintained in continuous 
culture on mixed soluble carbohydrate at a dilution rate of 0.05/hr, concentration of trans-
C18:1 were significantly reduced at a culture pH of 5.5. Because trans-C18:1 monoenes serve as 
a precursor of CLA, to maximize CLA synthesis in rumen diet need to be formulated to 
maintain ruminal pH above 6.0. 
5. Feeding strategies to enhance the CLA content in milk 
Milk fat is the richest natural dietary source of CLA.  Milk contains an average 4.5 mg 
CLA/g of fat (range 3-6 mg/g). The level of CLA in milk reflects the quantity, which is 
available for intestinal absorption (Loor and Herbein 1997). Therefore, there is a need to 
manipulate the feed in such a way to have higher CLA output in the reticulo-rumen for its 
increased absorption from the intestinal tract and eventually its secretion in the milk. 
Dietary factors that affect CLA content have been grouped into four categories related to the 
potential mechanisms through which they act (Bauman et al., 2001). 
1. The first category includes dietary factors that provide PUFA substrates for rumen 
production of CLA and trans-11 18:1. This typically corresponds to increasing the 
dietary supply of plant and/or fish oils.  
2. The second group consists of dietary factors that affect rumen bacteria involved in 
biohydrogenation, either directly or via changes in rumen environment. For example, 
modifying the forage: concentrate ratio of the diet, inclusion of ionophores and fish oil 
typically alters the biohydrogenation of PUFA. 
3. The third category includes dietary factors that involve a combination of lipid 
substrates and modification of rumen biohydrogenation. For example, several 
investigations have demonstrated that feeding fresh grass to dairy cows doubles the 
CLA content of milk fat (Lock and Garnsworthy, 2002) and this cannot be fully 
explained in terms of PUFA supply to the rumen. Other factors or components of grass 
must promote the production of CLA in the dairy cows. 
4. The fourth category is dietary supplements of CLA or trans-11 18:1 fatty acids. These 
must be protected from rumen biohydrogenation, typically with calcium soaps or 
formaldehyde. 
5.1 Vegetable oil – An effective feeding strategy 
Manipulation of animal diet primarily involves supplying linoleic acid or linolenic acid as 
substrates for rumen biohydrogenation. The vegetable/plant oil rich in these fatty acids 
seems to be an effective strategy for milk CLA manipulation in ruminants.  
Feeding plant seed oils, such as sunflower, soybean, peanut, canola, and linseed also 
increases CLA content in milk (Dhiman et al., 1999). There are a number of other research 
reports suggesting that feeding processed soybeans, canola, or flax seeds to dairy cows was 
more effective in increasing milk CLA content than feeding unprocessed seeds (Stanton et 
al., 1997; Chilliard et al., 2003).  
Kathirvelan (2007) reported that buffaloes fed with three different concentrate mixtures 
(Table 3) with different fatty acid composition (Fig 4) had different level of CLA (Table 4 & 
Fig 5) and concluded that milk CLA increased 185 percent in buffaloes fed on mustard oil 
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(2%) plus mustard cake containing rations (19.50 mg/g fat) as compared to GNC fed 
buffaloes (6.84mg/g fat). Tyagi et al. (2006), reported  higher level of total CLA (7.12 mg/ g 
fat)  on feeding 30 percent mustard oil cake in concentrate mixture to lactating buffaloes 
than those fed on GNC based concentrate mixture (6.74 mg/g fat). In another experiment, 
the same author reported (Table 5) that feeding berseem fodder to goats resulted in high 
milk CLA content (13.3 mg/g fat) than concentrate plus berseem fed goats (8.5 mg/g fat). 
 
Ingredients concentrate mixture
(GNC) 
concentrate mixture
(Mustard cake) 
concentrate mixture 
(Mustard cake+2% 
mustard oil) 
Groundnut cake 
(Expeller) 
27 - - 
Mustard cake 
(Expeller) 
- 39 39 
Mustard oil - - 02 
Maize 50 41 41 
Wheat bran 20 17 17 
Mineral mixture 02 02 02 
Salt 01 01 01 
Table 3. Ingredients in concentrate mixture (parts) 
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Fig. 4. The levels of C18:1, C18:2 and C18:3 in three different concentrate mixtures 
www.intechopen.com
 Conjugated Linoleic Acid: A Milk Fatty Acid with Unique Health Benefit Properties 
 
121 
 
Fatty acid concentrate mixture
(GNC) 
concentrate mixture
(Mustard cake) 
concentrate mixture 
(Mustard cake+2% 
mustard oil) 
C4:0 30.99  0.50 30.95  0.32 30.72  0.26 
C6:0 15.63  0.45 16.72  0.45 14.84  0.28 
C8:0 8.27 0.08 9.88  0.64 9.21  0.34 
C10:0 16.17 0.37 18.01 0.74 17.38  0.52 
C12:0 23.13 0.59 24.21  0.35 22.75  0.50 
C14:0 105.20 0.47 106.82  0.84 105.23  0.41 
C14:1 5.36 0.10 4.87  0.24 5.63  0.32 
C16:0 265.12  0.79 265.98 1.55 271.42  1.75 
C16:1 13.40  0.36 13.44   0.34 14.77  0.71 
C18:0 144.43a  2.19 139.33b   0.82 133.06c  1.06 
C18:1 9-t 1.73  0.17 1.96   6.03 1.94  0.12 
C18:1 9-c 238.41   1.68 238.27   0.89 239.98  1.16 
C18:1 11-c (VA) 9.55 a 0.45 13.01b  0.06 16.98 c  0.04 
C18:2 9-c,12-c 11.80 0.25 11.38  0.28 12.17  0.34 
C20:0 11.94  0.43 9.27  0.59 10.1 2  0.20 
C18:3 6-9-12-c 0.00   0.00 0.00  0.00 0.08   0.04 
C18:3 9-12-15-c 3.23  0.16 9.37  0.17 9.09   0.03 
Total C18:3 3.23 0.16 9.37  0.17 9.17  0.01 
C18:2 9-c,11-t 6.17a 0.25 10.51b 0.23 16.94c 0.30 
C18:2 10-t,12-c 0.67 a  0.08 1.61b  0.16 2.56 c 0.05 
Total CLA 6.84a  0.33 12.12b  0.04 19.50c  0.32 
Total Omega 3 FA 4.12 a  0.16 10.36b 0.25 10.50b 0.06 
Total Omega 6 FA 13.02   0.34 12.64 0.38 12.47 0.36 
Omega 6 : Omega3 3.18 a  0.15 1.22b 0.02 1.19b  0.03 
Values are Mean   SE for n=5  
Values with different superscript across a row differ significantly (P<0.05) 
Table 4. Fatty acid composition (mg/g fat) in milk 
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Fig. 5. Total CLA in milk (mg/g of fat) at fort night intervals (Zero day or first sampling 
after 30 days of adaptation period 
 
Attribute Treatment 
Group I Group II 
Fat (%) 3.7  0.15 3.8 0.08 
SNF (%) 6.6 0.19 7.0  0.16 
Total solids (%) 10.3  0.43 10.8  0.26 
CP (%) 3.5  0.12 3.5  0.19 
Fatty acids ( mg per g) 
C4-14 203.0a 7.21 227.8 b 5.23 
C15:0 18.70.65 21.40.53 
 
C16:0 253.54a 7.21 255.4 b 6.14 
C18:0 134.0 a 4.25 148.9 b 4.28 
C18:1 11-trans 
(TVA) 
50.8 a 1.52 35.4 b 0.85 
C18:1 9-c 200.1 a 5.24 231.2 b 4.56 
C18:2 9-c, 11-t 18.5 a 1.12 10.5 b 0.98 
C18:2 10-t, 12-c 
 
0.50.08 
 
0.40.04 
 
Total CLA 18.9 a 1.30 10.94 b 1.15 
C18:3 13.3 a 0.80 8.5 b 1.30 
Values with different superscripts across a row differ significantly (P<0.01) 
Table 5. Milk composition of goats fed with berseem and berseem plus concentrate 
www.intechopen.com
 Conjugated Linoleic Acid: A Milk Fatty Acid with Unique Health Benefit Properties 
 
123 
Besides, the feeding of fish oil has been shown to enhance the CLA contents of milk fat. In 
some studies, fish oil/ fish meal was more effective at enhancing the CLA content of milk 
than adding similar amounts of soybean oil or combinations of fish oil and soybean oil 
through extruded soybeans or soybean meal (Ramaswamy et al., 2001) since fish or marine 
oils are usually rich in long chain PUFA.  The inclusion of marine feeds, such as fish meal or 
sea algae, into dairy cow diets has also been shown to enhance the CLA content of milk 
(Abu-Ghazaleh et al., 2002) 
5.2 Fatty acid composition of different vegetable oils 
Dietary effect on CLA content is related probably more to the fatty acid composition of the 
diet/ feed used than any other factor. Poly unsaturated fatty acid composition of different 
oils ( Table 6)  and fatty composition of feeds and fodders used at  NDRI cattle yard are 
reported in Table 7 (Kathirvelan, 2007) 
 
Plant oil Oleic acid (%) Linoleic acid (%) Linolenic acid (%) 
Sunflower oil 22.8 67.0 0.45 
Soybean oil 19.5 53.2 9.1 
Corn oil 27.3 57.5 1.0 
Cotton seed oil 16.5 57.4 0.33 
Mustard oil 24.12 41.16 9.54 
Ground nut oil 46.77 35.67 0.58 
Linseed oil 17.7 15.4 57.2 
Table 6. Oleic, Linoleic and Linolenic fatty acids concentration in different vegetable oils 
 
Fatty acid Maize 
Fodder 
Wheat 
straw 
Wheat 
bran 
Maize 
grain 
Groundnut 
cake 
Mustard 
cake/oil 
C14:0 1.82 1.26 0.89 0.42 0.53 0.45 
C16:0 11.24 10.91 20.12 15.14 14.72 8.33 
C16:1 0.00 0.00 0.00 0.11 0.00 0.24 
C18:0 5.41 0.00 4.26 3.25 7.28 1.45 
C18:1 6.62 7.15 16.35 28.42 46.77 24.12 
C18:2 12.69 10.15 48.90 47.07 25.67 41.16 
C18:3 45.26 0.00 4.06 1.02 0.96 9.54 
C20:0 0.00 0.00 0.00 0.00 0.00 0.36 
C22:1 0.00 0.00 0.00 0.00 0.00 17.82 
Table 7. Fatty acids composition of feeds and fodders (% of total fatty acids)  
6. Effect of milk process on CLA content in dairy products 
Processing of milk into a number of dairy products under normal conditions has no 
influence on the CLA contents (Shantha et al., 1995). Use of different starter culture, 
processing conditions and aging periods had negligible effect on the total CLA 
concentration in dairy products (Shantha et al., 1995).  Kathirvelan (2007) reported that when 
milk was converted into ghee by creamery method, similar level of CLA was found in ghee 
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(19.54 mg/g fat) as in milk (19.50mg/g fat). Tyagi et al (2007) reported an increased level of 
CLA in ghee prepared by the indigenous method of ghee preparation due to lactic culture 
fermentation but no such increase was found in cheese and paneer (Table 8). However, 
Aneja and Murthi (1990) reported substantial increase in CLA content in ghee during its 
clarifying process at 120oC.  
 
 
*P<0.01 The nutritional requirements of Group-I buffaloes were fulfilled through concentrate mixture, 
In Group- II concentrate mixture + Berseem and in Group –III, Berseem only. 
Table 8. Level of CLA (mg/g) in buffalo milk and the dairy products prepared through 
different processing treatments 
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7. Potential health benefits of CLA 
The biological properties of dietary CLA are currently attracting considerable interest 
because of its diverse physiological outcomes in animal studies. Beyond its nutritional 
value, dietary CLA is effective in suppressing tumor development during initiation, 
promotion and progression phases of carcinogenesis (Belury, 2002). Not only CLA is a 
powerful anticarcinogen, but it also has antiatherogenic, immunomodulating, growth 
promoting, lean body mass enhancing and antidiabetic properties. Hence CLA is considered 
being a functional food.  
Growing evidences suggest that CLA has numerous health benefits towards human being.  
Milk and meat from ruminants are richest natural source of CLA, which has been shown to 
have anticancer properties (Parodi, 1994). CLA reduced plasma lipoproteins and early 
atherosclerosis in animals (Lee et al., 1994). CLA was able to normalize impaired glucose 
tolerance in diabetic rats (Houseknecht et al., 1998). CLA has been shown to have 
immunomodulatory properties by enhancing mitogen induced lymphocyte blastogenesis, 
lymphocyte cytotoxic activity and macrophage killing ability (Wong et al., 1997) 
7.1 Anticarcinogenic property of CLA 
The recent interest in CLA began with the isolation from hamburger meat as an 
anticarcinogenic factor. Partially purified extracts from fried ground beef was shown to 
contain mutagenic modulator activity inhibiting the initiation of mouse epidermal 
carcinogenesis by 7, 12-dimethylbenz[a]anthracene, a pro-carcinogen (Ha et al. 1987). CLA 
was repeatedly shown to have anticarcinogenic effects in animal models for stomach 
neoplasia (Ha et al. 1990), mammary tumors (Ip et al., 1997), and skin papillomas (Belury et 
al. 1997). As low as 0.05% level of CLA is enough to significantly decrease the induced 
mammary tumors in rodents (Ip et al. 1997). CLA is effective in reducing the size and 
metastasis of transplanted human breast cancer cells and prostate cancer cells in severely 
compromised immunodeficient mice. CLA-enriched butterfat was reported to alter 
mammary gland morphogenesis and also to reduce the risk of cancer in rats (Ip et al., 1997).  
Kathirvelan (2007) reported that feeding CLA enriched ghee (composition of rat diet given 
in Table 9)  lowered around 37 percent gross tumors incidence (Table 10) in 7, 12 dimethyl 
benz (a) anthrazene induced mammary gland carcinogenesis in female Wistar rat than the 
control (soybean oil based diet) group. The mean tumour weight was high in soybean oil fed 
group (3.30 g) (Fig 6 & Fig 7) than the high CLA ghee fed group (1.29 g) (Fig 8).  The 
common type of tumour (benign) found in the three groups were fibroma, adenoma and 
fibroadenoma but adenocarcinoma (malignant) type (Fig 9) was found only in soybean oil 
based diet group. Thus, CLA feeding not only inhibited the benign type tumour but 
malignant tumour as well. 
7.2 Cancer modulation mechanism of CLA 
There are various intriguing possibilities regarding its anti-carcinogenic action. However, 
the concrete anti-carcinogenic mechanism still is unclear. 
7.3 CLA acts as an antioxidant 
This is the first theory proposed in support of its anticarcinogenic action. CLA through 
dietary fat gets incorporated into neutral lipids and phospholipids, preferably in the former. 
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They act as free radical scavengers thereby providing an in situ ‘defence mechanism’ against 
membrane attack by dangerous oxygen free radicals (Ha et al., 1990). 
 
 
 
Component Soybean oil  based 
diet 
Low CLA 
(12.12 mg/g fat)  
ghee based diet 
High CLA  
(19.54mg/g fat) 
ghee based diet 
Bengal gram 540.0 540.0 540.0 
Wheat 130.0 130.0 130.0 
GNC 60.0 60.0 60.0 
Soybean oil 200.0 - - 
Low CLA ghee - 200 - 
High CLA ghee - - 200 
Skimmed  milk powder 44.4 44.4 44.4 
Mineral mixture 21.6 21.6 21.6 
Vitamin mixture 2.0 2.0 2.0 
Choline chloride 2.0 2.0 2.0 
Table 9. Composition of rat diets (g/kg of diet) 
 
 
 
Groups Percent 
tumour 
incidence* 
Percent Individual tumour incidence Mean 
tumour 
weight 
(g) 
Fibroma Adenoma Fibro 
adenoma 
Adenoma 
sarcoma 
Soybean oil  
based diet 
83.33 
(25/30) 
36.00 
(9/25) 
24.00 
(6/25) 
28.00 
(7/25) 
12.00 
(3/25) 
3.30  
1.39 
Low CLA 
(12.12 mg/g fat)  
ghee based diet 
63.33 
(19/30) 
42.11 
(8/19) 
21.05 
(4/19) 
36.84 
(7/19) 
0.00 2.42  
0.88 
High CLA 
(19.54mg/g fat) 
ghee based diet 
46.70 
(14/30) 
57.14 
(8/14) 
14.29 
(2/14) 
28.57 
(4/14) 
0.00 1.29  
0.27 
Table 10. Effect of feeding CLA enriched ghee on mammary gland tumour incidence in 7, 12 
DMBA administered rats 
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 Rats were killed 32 weeks after DMBA administration 
* Includes both palpable and histo pathological examination 
Fig. 6. Rat showing the mammary tumour with the diameter approximately 3.4 cm (Soybean 
oil based diet) 
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Fig. 7. Excised tumour showing 3.0 cm diameter (Soybean oil based diet) 
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Fig. 8. Rats showing tumour with diameter of 1.1 cm (CLA ghee based diet) 
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(Soybean oil based diet)   H&E x 400 
Fig. 9. Adenocarcinoma showing stromal invasions with tumor cells   
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Compared with other antioxidants, CLA has been shown to be more potent antioxidant. It is 
more potent than alpha-tocopherol and as effective as butylated hydroxytoluene (BHT) in 
inhibiting iron-thiocyanate induced peroxide formation. In addition, CLA was shown to be 
as effective as vitamin E and butylated hydroxyanisole in inhibiting the formation of thio 
barbituric acid reactive substances (TBARS), as a bio marker often used to assess oxidation 
in biological systems.  
Liver is the major organ in which most of the chemicals, drugs and carcinogens undergo 
metabolism (Krishnaswamy and Raghuramulu, 1999). Several environmental carcinogens 
have been reported to elicit hepatic oxidative stress and alter the activities of detoxifying 
and antioxidant enzymes during extra hepatic tumorigenesis (Aruna and Sivaramakrishnan, 
1996). Antioxidant and detoxification enzymes can block carcinogenesis by acting as 
inhibitors of environmental carcinogens or mutagens (Cunningham and Lokesh, 1983). 
Catalase and superoxide dismutase are the primary antioxidant enzymes involved in direct 
elimination of toxic free radicals which may result in amelioration of oxidative damage. 
Amelioration of oxidative damage by scavenging of free radicals formed during oxidative 
stress may protect cell against carcinogenicity and toxicity (Ketterer et al., 1990). Glutothione-S-
transferase is a biotransformation enzyme involved in the detoxification of  xenobiotics, 
carcinogens, free radicals and peroxides by conjugating these toxic substrates with GSH 
(Glutathione reduced) thus ultimately protecting cells and organs against induced toxicity. 
Hence, enhancement of these enzymes by a natural or synthetic component may result in the 
amelioration or inhibition of extra hepatic tumorigenesis and CLA acts as chemopreventive 
agent by counteracting the carcinogen induced oxidative stress and elevating the levels of 
detoxifying enzymes (Ip et al., 1999).  Ip et al. (1999) have clearly established a relationship 
between dietary CLA, oxidation and mammary carcinogenesis. Dietary CLA 0.25% or higher 
reduced the formation of TBARS in non initiated mammary tissue in vivo in parallel with CLA 
inhibition of mammary carcinogenesis.  Kathirvelan (2007) observed that feeding CLA 
enriched ghee resulted in increased antioxidative as well as detoxifying enzymes in liver and 
mammary gland than the soybean oil based diet fed rats (Table 11). 
 
Liver enzymes Cancer groups 
Soybean oil based 
diet 
Low CLA  
ghee based diet 
High CLA  
ghee based diet 
Catalase (U/mg protein) 
 
479.91a 11.9 609.60 b7.62 730.67 c11.36 
SOD (U/mg protein) 
 
9.63 a0.79 15.86 b0.84 20.60 c 1.41 
GST (U/mg protein) 
 
0.79 a  2.50 1.19 b  3.77 1.42 c  4.51 
Mammary gland 
Catalase (U/mg protein) 
 
22.26 a1.71 35.66 b  1.41 47.52 c  1.43 
Values are Mean SE for n=12, One CAT Unit (U) is equivalent to 1mol of H2O2 consumed /minute/ 
mg of protein at 25C, One SOD unit is equivalent to the amount of enzymes that inhibit the reaction 
50% , One GST unit is expressed as mmoles of cDNB conjugated /minute/mg protein. 
Values with different superscript across a row  differ significantly at (P<0.05)  
Table 11. Effect of feeding CLA enriched ghee on liver and mammary gland enzymes 
activities in cancer induced groups  
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7.4 Inhibit arachidonic acid (C20:4) derived eicosaonoid metabolism in the target organ 
(Belury et al., 1997)  
Many types of cancer cells have an enzyme called cycloxygenase (Cox-2) and use it as a 
biological fuel to propagate rapidly. CLA inhibits the enzyme thereby modulation the 
prostaglandin biosynthesis from linoleic acid in normal course (Urquhart et al, 2002).  The 
prostaglandins (PGE2) secreted by cancer cells under the activity of Cox-2 acts as a tumor 
promoter. Unusual PUFAs (C18:3. C20:3) derived from CLA leads to the formation of 
arachidonic acid which behaves differently than that of its usual nature when derived from 
linoleic acid in normal course (Iwakiri et al, 2002). This cerueval behavior leads to 
eicosaonoid inhibition viz. inhibition of prostaglandins and leukotrienes which further leads 
to reduction of diacylglycerol (Tumor promoting factor) upto 50% (Kritchersky et al, 2000). 
The cancer preventive activity of CLA is unlikely to be indicated by interference with the 
metabolic cascade involved in converting linoleic acid to eicosaonoid. 
7.5 Reduce the formation of carcinogen – DNA adducts 
CLA leads to a reduced formation of a carcinogen and DNA adducts (Moon et al, 2003) in a 
similar manner to substrate legend binding. This may be due to CLA check at the initiation 
point of carcinogenesis further preventing the binding of electrophile intermediates of DNA 
thereby causing permanent DNA lesion. This DNA containing cell when allowed to 
proliferate under promotion stage may lead to neoplastic cell. 
7.6 Stimulate the lymphocyte proliferation 
The lymphocytes had enhanced proliferation when stimulated with CLA, in vivo and in vitro 
(Miller et al, 1994) when a blend of isomers (cis-9, trans-11 and trans-10 cis-12) in the ratio 
80:20 are given through the diet, the lymphocyte proliferation is observed (Majumdar et al, 
2002). This in turn enhances cellular immunity by modulating phenotype and effect or 
functions of CD8+ lymphocytes (cells involved in both adaptive and innate immunity) 
involving T-cell receptors. The CD8+ lymphocytes are essential for the development of cell 
mediate protection against neoplastic cells. CLA enhanced the cytotoxic potential of 
peripheral blood lymphocytes by inducing the proliferation of cytotoxic CD8+ cells. Further, 
CLA was found to increase CD4 lymphocyte population and NK cell function and number 
(Ochoa et al, 2004). CD4 cells get differentiated into cytokines TH1 cells and TH2 cells 
(Thymus responsive cells). The TH1 cells produce interleukin 1, 2 and -interferon, activate 
macrophages and further delayed hypersensitivity reaction whereas TH2 cells produce 
interleukin -4, 5, 10 induces esinophiles decrease in number (CLA has anti allergic effect) 
and is more specialized in inducing B cells for immunoglobin production (CLA has immune 
stimulation effect) interleukin 1, 2 so derived by induction of TH1 responsive cells further 
stimulate growth of -interferon in T-cells and NK cells. The -interferon inhibits PGE2 
synthesis which acts as a tumor promoter factor. Gamma interferon kill tumour either by 
usual mechanism of secretion of tumour necrosis factor (TNF) or by activated macrophages 
mediated selective cellular toxicity. NK cells in addition to direct lysis of tumour cells can 
also participate in antibody dependant cellular cytotoxicity. 
7.7 Modulate the activity of phase-1 enzymes of Mixed Function Oxidase system 
(Benjamin et al, 2003) 
CLA has been found to modulate the activity of Cytochrome-P450 (Cyt.P) and reduce the 
induction of ornithine decarboxylase (ODC) and GTPase activating protein kinase C (PKC). 
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This facilitates the oxidation and reduction of Cyt.P and hydroxylation as a result of which 
activated toxicant-Cyt.P complex and subsequently hydroxylated toxicant is available in the 
end of phase-1 reaction. The enzymes ODC+PKC play key roles in the activation of 
carcinogens and therefore are tumor production indicators. 
7.8 Modulate gene expression (Carta et al, 2002) 
The potential molecular mechanism by which CLA shows its anti-carcinogenic activity says 
that CLA acts as a legend for peroxisomes proliferation receptor (PPAR) which is a steroid 
hormone receptor (nuclear receptor) . This binding after the transcription process through 
sequential steps. The regulatory gene is lost and so the target genes are altered. This activates 
the endonuclease action; influx of Ca2+ takes place in the cytoplasm which leads to DNA 
fragmentation. The cell growth and differentiation is arrested and thus induce apoptosis. 
7.9 CLA and atherosclerosis 
While considerable research has focused on a potential anticarcinogenic effect of CLA, there 
are few studies indicating that CLA may also reduce the risk of cardiovascular diseases in 
animal models. Unlike linoleic acid, there is a paucity of information regarding the effect of 
dietary conjugated linoleic acid on plasma lipoproteins and aortic atherosclerosis.  
Lee et al.(1994) first tested whether CLA might affect the initiation and progression of 
atherosclerosis lesions in rabbits through its effect on lipid peroxidation. They reported that 
rabbits fed an atherogenic diet and supplemented with 0.5g CLA per day for 22 weeks had 
significantly less plasma triglyceride, plasma LDL-cholesterol (LDL-C) and LDL-C/HDL-C 
ratio than control animals. CLA feeding also resulted in fewer aortic fatty lesions. 
Subsequently, (Nicolosi et al., 1997) reported that hamsters fed CLA collectively had 
significantly reduced levels of plasma total cholesterol, non-high density lipoprotein 
cholesterol, (combined very-low and low-density lipoprotein) and triglycerides with no 
effect on high density lipoprotein cholesterol, as compared to controls. Kathirvelan (2007) 
reported that low and high CLA feeding reduced total cholesterol by 52.17 and 26.06 
percent, triglycerides by 23.00 and 11.00 percent, however, HDL-c increased by 17.82 and 
33.26 percent than soybean oil fed rats (Table 12). He concluded that, antiatherogenic 
property of CLA was proved by decreasing the total cholesterol, triglycerides, LDL- 
cholesterol (Fig 10) and atherogenic index (Fig. 11) and increasing the HDL-cholesterol 
blood plasma. In addition to this, the level of cholesterol and triglyceride deposition in liver 
and aorta were lower in CLA fed groups (Table 13). 
In the literature, dietary CLA has been reported to have controversial results on atherosclerosis 
in mice. Noone et al., (2002) reported that CLA actually did not reduce the incidence of 
atherosclerosis, but increased the incidence of fatty acid streaks in mice compared to control-
fed mice. Study conducted by Munday et al. (1999) contradicts the finding of studies 
conducted in rabbits and hamsters (Lee et al., 1994: Nicolosi et al., 1997). It is possible that 
dietary CLA has different influences on the fatty acid and cholesterol metabolism in different 
animal species. More research is necessary to elucidate the effects of dietary CLA on lipid 
metabolism and atherogenesis in animal models and eventually human beings. 
Since it is difficult to study the effect of CLA on atherosclerosis in humans, an indirect 
approach by measuring various potential heart disease markers is required (Belury and 
Kempa-steczko, 2000). Lipid atherogenic risk markers were more favorably influenced by 
cis-9, trans-11 isomer than a mixture of CLA or fish oil (Valeille et al., 2004) when healthy 
human subjects were used in a double-blind placebo controlled intervention trial. Noone et 
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al. (2002) demonstrated that CLA isomers improved very low-density lipoprotein 
cholesterol and plasma triacylglycerol metabolism suggesting that some of the cardio-
protective effects of CLA shown in animal studies were relevant to humans as well. 
 
Parameters Base line 
levels 
Groups 
Soybean oil 
based diet 
Low CLA ghee
based diet 
High CLA ghee 
based diet 
Total Cholesterol 
(mg/dL) 
58.09  1.24 81.33a  2.91 74.40 b  1.68 69.93c  1.44 
HDL-C (mg/dL) 34.72  0.78 35.51a  0.91 41.84b  0.54 47.32c  0.96 
Triacylglycerol 
(mg/dL) 
40.87  0.77 73.23a   1.08 65.01b 1.16 56.21c  0.42 
LDL-C (mg/dL) 14.26  1.72 26.79a  3.53 19.57b  1.86 14.38c   1.62 
Atherogenic Index 
(AI) 
0.410  0.06 0.971a  0.12 0.570b  0.05 0.244c  0.04 
Values are MeanSE for n=8 
Values in rows with different superscript differ significantly (P<0.05) 
Table 12. Plasma Lipids profile of Wistar rats at baseline and after 16 weeks of CLA enriched 
ghee feeding. 
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Fig. 10. Plasma LDL (mg/dL) levels in rats fed on CLA enriched ghee diet 
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Fig. 11. Atherogenic index in rats fed on CLA enriched ghee diet 
 
Groups Liver Aorta 
Cholesterol Triglycerides 
 
Cholesterol 
 
Triglycerides 
Soybean oil based 
diet 
1.05a  0.029 10.08a 0.145 9.46a  0.029 7.06a 0.073 
Low CLA ghee 
based diet 
0.84b  0.013 7.12b  0.218 6.95b  0.015 5.09b  0.123 
High CLA ghee
based diet 
0.53c  0.008 4.50c  0.143 3.64c  0.009 2.49c  0.109 
Values are Mean  SE for n=8 
Values in rows with different superscript differ significantly (P<0.01) 
Table 13. Lipid profile (mg/g tissue) in liver and aorta tissue of rats fed on CLA ghee diet 
7.10 CLA and lipid metabolism 
A major effect of CLA in this respect is the reduction in lipid uptake by adipocytes (Pariza et 
al., 2003) which leads to the reduction in body fat gain (Kim et al., 2002). Azain et al. (2000) 
reported that the reduction in body fat mass in rats was the result of reduced adipose tissue 
size rather than cell number. Similarly Poulous et al. (2001) found a reduction in cell size, but 
not the cell number in rats which had less body fat in response to CLA supplementation. 
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Carta et al. (2002) concluded that a regular intake of CLA and or TVA as its precursor should 
work as an excellent preventive agent that would modulates lipid metabolism. Kathirvelan 
(2007) found that feeding CLA ghee (20 % in the diet) to male wistar rats doesn’t increase 
the body weight as compared to the control group (Table 14) 
 
week Average weekly body weight (gram) 
Soybean oil diet 
(Control) 
Low CLA ghee 
diet 
High CLA ghee 
diet 
0 131.13  4.70 125.00  2.85 128.57  3.45 
2 169.29  5.09 165.01  4.03 163.14  4.68 
4 187.86  6.04 185.08  6.22 185.71  7.02 
6 203.57  3.45 198.52  5.59 195.29  4.17 
8 215.00 5.34 214.29  7.58 212.86  4.93 
10 231.69  8.55 228.33  7.42 227.51  6.95 
12 243.33  7.42 240.00  6.35 239.17  4.47 
14 254.00  5.88 257.50  8.14 252.51  6.32 
16 263.33  4.81 265.00  6.67 262.12  4.21 
Over all mean 211.02 13.51 208.8114.23 207.43 13.73 
Values are Mean SE for n=8 
Table 14. Average weekly body weight of rats fed on CLA enriched ghee diet 
Studies in rats and mice have shown that feeding CLA at the level of 0.5% in total diet 
produced small reduction in body fat gain in growing animals (Pariza et al., 1997; Park et al., 
1997). Whilst the actions of CLA in inhibiting body fat accumulation have received 
considerable attention because of increasing concern for marked increases in obesity in 
western societies, care should be taken in extrapolating these findings to man until more 
information is available. The specific mechanism by which dietary CLA reduces body fat 
content is likely to vary from one animal species to another. The results of animal studies are 
also not conclusive. The mechanism by which CLA alters lipid metabolism and body 
composition in animals is not fully elucidated. It may be tissue and species-specific. In 
rodents, CLA-induced alteration of lipid metabolism appears to involve increase in rates of 
lipolysis and fatty acid oxidation. Support for this mechanism comes from the observation 
of increased hormone sensitive lipase activity and enhanced carnitine palmitoyl transferase 
activity in several tissues of mice fed CLA (Pariza et al., 2003). 
Peroxisome proliferators activated receptor alpha (PPAR), one of the nuclear receptors 
related to the modulation of environmental and dietary stimuli (Schoonjan et al., 1996), is 
likely to be involved in the regulation of the gene expression of fatty acid beta oxidation 
enzymes by dietary CLA. It has been demonstrated that CLA is a potent legend and 
activator of PPAR (Belury et al., 1997) but Peterson et al. (2003) observed that a mixture of 
CLA isomers increased the gene expression of hepatic fatty acid beta oxidation enzymes 
through both PPAR dependent and independent mechanisms. The activity of fatty acid 
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synthatase (FAS), a key enzyme of fatty acid synthesis, was also significantly decreased by 
dietary CLA as compared to the control diet in the liver of rats. 
7.11 CLA and diabetes  
Feeding of CLA to rats prone to developing diabetes normalized glucose tolerance and 
improved hyperinsulinemia as effectively as currently used medications (Houseknecht et al., 
1998). CLA was fed at 1.5% (by weight) of the diet for 2 week in diabetes induced rats. The 
study was short-term and needs to be replicated and extended before the results can be 
applied to human health. Nonetheless, if CLA can improve glucose homeostasis and inhibit 
body fat accretion as demonstrated in mice, rats, and pigs, then CLA may be beneficial to 
humans prone to diabetes (Ip et al., 2003)  
7.12 CLA and immune system:  
Cook et al (1993) showed that CLA not only enhances immune response, but also protects 
tissues from collateral damage. Sugano et al (1999) proposed that the immune enhancing 
effect of CLA was by modulating eicosanoid and immunoglobin production. CLA also 
diminished lipopolysaccharide induced inflammatory events in macrophages through 
reduced mRNA and protein expression  of nitric oxide synthatase and cyclooxigenase-2 as 
well as subsequent production of  nitric oxide and prostaglandin E2 (Cheng et al., 2004). 
Kathirvelan (2007) observed that feeding of CLA enriched ghee to mammary gland cancer 
induced female wistar rats reduced level of plasma nitric oxide than the non CLA fed rats 
(Table 15). Cook et al (1993) suggested that CLA prevents immune associated wasting by 
 
Days Cancer groups 
Soybean oil 
based diet 
Low CLA ghee 
based diet 
High CLA ghee 
based diet 
0 9.25a 0.31 8.59a 0.17 8.41a 0.18 
30 18.52a 0.33 16.45b 0.41 15.45c 0.38 
60 25.70a 0.50 19.44b 0.20 18.38c 0.23 
90 30.28a 0.49 25.43b 0.22 23.43c 0.45 
120 38.18a 0.33 33.16b 0.53 28.20c 0.28 
150 40.92a 0.50 35.34b 0.31 32.54c 0.25 
180 42.46a 0.46 35.83b 0.54 32.24c 0.37 
210 43.26a 0.29 38.50b 0.28 33.20c 0.15 
240 43.00a 0.41 37.56b 0.34 33.07c 0.47 
Over all 
mean 
32.40  3.87 27.81  3.39 24.99  2.86 
Values (mol/ml) are Mean  SE for n=12 
Values in a row with different superscript differ significantly (P<0.05)  
Table 15. Effect of feeding CLA enriched ghee diet on plasma nitric oxide (mol/ml) level in 
mammary gland cancer induced rats 
 protecting nonlymphoid tissues from the adverse effects of cytokines, which are growth 
suppressants, because CLA influences the immune system by altering the effects of 
cytokine, interleukin, leukotriene and many immunoglobulin. Sebedio et al., (2000) 
hypothesized that CLA indirectly affects the function/production of tumor necrosis factor-α 
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(TNF-α) and interleukin-1 (IL-1). Yu et al. (2002) has shown that CLA exhibits anti-
inflammatory effects by negatively regulating the expression of certain pro-inflammatory 
genes. By inducing the activity of peroxisome proliferators activated receptor gamma 
(PPAR-γ) via CLA, there is a decrease in the production of pro-inflammatory products such 
as nitric oxide and TNF-α (Yu et al., 2002).  
7.13 CLA and bone metabolism 
Watkins et al (1999) found a higher rate of bone formation in chicks fed butterfat, which was 
suggested to be due probably to increased CLA intake. Dietary CLA led to differences in 
CLA enrichment of various organs and tissues, bone marrow and periosteum containing the 
highest concentration of CLA and brain the lowest. Enrichment of chondrocytes with CLA 
affected collagen synthesis in a dose dependent fashion (Watkins et al., 1999). Reduced 
production of arachidonic acid and PGE2 in the chondrocytes was suggested to be the 
possible mechanism. Such changes in bone biomarkers and bone formation rates in rats 
were associated with increased cis-9, trans-11 CLA in bone tissue lipids. McDonald (2000) 
suggested that increased ash content in CLA fed animals (Park et al, 1997) is due to 
protection of bone loss from cytokines. Further investigation is needed as to how bone 
metabolism is affected by CLA and mechanism of action related with it. 
8. Conclusion 
Conjugated linoleic acid is unique; unlike the most naturally occurring anticarcinogenic 
substances found mainly in plants, it is present in food from animal sources. Milk fat is the 
richest natural source of CLA and could be increased by manipulation of the nutritional 
regimes of the animals. Diverse biological roles of CLA in mediating cancer, diabetes, lipid 
metabolism, atherosclerosis, immune function, bone modeling etc. observed in animal 
models are quite compelling. Although there have been a few attempts at verifying the 
positive effects of CLA in human health through case control studies, it is not yet possible to 
clearly state that CLA supports all the those benefits in humans as well. Limited available 
literature in humans, however also supports the findings observed in animals and tissue 
culture models even though the results are inconclusive and even conflicting at times. As a 
result, natural enrichment of food products through manipulation of animal diet may 
contribute to the overall goal of obtaining the positive health benefits associated with CLA 
in the immediate future. 
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